News | Ultrasound Imaging | October 10, 2016

Toshiba Highlighting Ultrasound Contrast Imaging at RSNA 2016

Company will display latest contrast packages for Aplio 300 and 500 Platinum systems, along with live scanning on the show floor

Toshiba America Medical Systems, ultrasound, Aplio 300 Platinum, Aplio 500 Platinum, contrast, live scanning, RSNA 2016

October 10, 2016 — Toshiba America Medical Systems Inc. announced it will be displaying a wide array of diagnostic imaging technologies at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 2 in Chicago, including the latest advances in ultrasound.

To expand the clinical utility of ultrasound, Toshiba will be showcasing its comprehensive contrast imaging package on the Aplio 500 Platinum and Aplio 300 Platinum systems. Given the recent U.S. Food and Drug Administration (FDA) approval of ultrasound contrast for characterizing liver lesions in adults and pediatrics, the Aplio Platinum Series’ contrast-enhanced ultrasound capabilities allow clinicians to make more confident diagnoses, and may help reduce the need for additional computed tomography (CT) or magnetic resonance imaging (MRI) exams. The Aplio Platinum Series provides powerful clinical imaging tools for advanced visualization, quantification and intervention. This delivers a less expensive and safer diagnostic imaging option with no radiation.

In addition, live ultrasound scanning will take place on the RSNA show floor for the first time this year and Toshiba will demonstrate the advanced capabilities of its premium ultrasound systems. Live abdominal, thyroid, musculoskeletal (MSK) and vascular imaging will showcase the visualization benefits of technologies like Toshiba’s Superb Micro-Vascular Imaging (SMI) and Shear Wave elastography. The company will also reveal new and intuitive system ergonomics that will help boost productivity during daily routine and complex exams.

For more information: www.medical.toshiba.com

Related Content

Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS. 

Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS. 

News | Artificial Intelligence | November 12, 2020
November 12, 2020 – Konica Minolta Healthcare Americas Inc. and DiA Imaging Analysis Ltd.
An injured sonographer can be detrimental to institutions and clinics facing financial strain and lack of workforce readiness due to COVID-19.  
Sponsored Content | Case Study | Ultrasound Imaging | November 12, 2020
There is a high incidence of ultrasound work-related musculoskeletal disorders (WRMSD) among...
Enhanced axial CT (A) shows diffuse pleural thickening (arrow) with a maximum thickness of 3.17 mm. US image for the corresponding lesion on CT (B) shows diffuse pleural thickening (arrowheads) with a maximum thickness of 3.25 mm. The needle pathway length, measured as the needle length through the pleural lesion, was 6.54 mm (asterisk). Pleural puncture angle (exact value not indicated) is depicted as the angle between the outer line of the pleura and the biopsy needle (thin arrow).

Enhanced axial CT (A) shows diffuse pleural thickening (arrow) with a maximum thickness of 3.17 mm. US image for the corresponding lesion on CT (B) shows diffuse pleural thickening (arrowheads) with a maximum thickness of 3.25 mm. The needle pathway length, measured as the needle length through the pleural lesion, was 6.54 mm (asterisk). Pleural puncture angle (exact value not indicated) is depicted as the angle between the outer line of the pleura and the biopsy needle (thin arrow).

News | Ultrasound Imaging | November 09, 2020
November 9, 2020 — According to an
Honoring essential healthcareprofessionals, Nov. 8-14
News | Radiology Imaging | November 09, 2020
November 9, 2020 — As COVID-19 continues to spre
Conceptual diagram of bio-organizational crushing technology based on high-intensity concentric ultrasonography. Image courtesy of Korea Institue of Science and Technology(KIST)

Conceptual diagram of bio-organizational crushing technology based on high-intensity concentric ultrasonography. Image courtesy of Korea Institue of Science and Technology(KIST)

News | Ultrasound Imaging | November 02, 2020
November 2, 2020 — Focusing ultrasound energy on a target site in the body to generate heat can burn and destroy the
Murray Rebner, M.D., performing a breast ultrasound. Image courtesy of Beaumont Health

Murray Rebner, M.D., performing a breast ultrasound. Image courtesy of Beaumont Health

News | Breast Imaging | November 02, 2020
November 2, 2020 — Though Black women get ...
José Obeso, MD, PhD, (left) of of the Centro Integral de Neurociencias (HM CINAC) in Madrid and Nir Lipsman, MD, PhD, (right) of Sunnybrook Health Sciences Centre in Toronto. Each doctor is leading a clinical trial using focused ultrasound to target the striatum in patients with Parkinson's disease.

José Obeso, MD, PhD, (left) of of the Centro Integral de Neurociencias (HM CINAC) in Madrid and Nir Lipsman, MD, PhD, (right) of Sunnybrook Health Sciences Centre in Toronto. Each doctor is leading a clinical trial using focused ultrasound to target the striatum in patients with Parkinson's disease.

News | Focused Ultrasound Therapy | October 30, 2020
October 30, 2020 — A team of researchers in Madrid, Spain, and another team in Toronto, Canada, are the first in the
Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health S

Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health System

News | Ultrasound Imaging | October 28, 2020
October 28, 2020 — Card...